Format

Send to

Choose Destination
Clin J Am Soc Nephrol. 2014 Jun 6;9(6):1138-40. doi: 10.2215/CJN.01450214. Epub 2014 Apr 3.

Glomerular disease: looking beyond pathology.

Author information

1
Due to the number of contributing authors, the affiliations are provided in the Supplemental Material.
2
Due to the number of contributing authors, the affiliations are provided in the Supplemental Material. flessnermf@niddk.nih.gov.

Abstract

The National Institute of Diabetes and Digestive and Kidney Diseases-supported Kidney Research National Dialogue asked the scientific community to formulate and prioritize research objectives aimed at improved understanding of kidney function and disease progression. Over the past 2 years, 1600 participants posted almost 300 ideas covering all areas of kidney disease. An overriding theme that evolved through these discussions is the need to move beyond pathology to take advantage of basic science and clinical research opportunities to improve diagnostic classification and therapeutic options for people with primary glomerular disease. High-priority research areas included focus on therapeutic targets in glomerular endothelium and podocytes, regenerating podocytes through developmental pathways, use of longitudinal phenotypically defined disease cohorts to improve classification schemes, identifying biomarkers, disease-specific therapeutics, autoantibody triggers, and changing the clinical research culture to promote participation in clinical trials. Together, these objectives provide a path forward for improving clinical outcomes of glomerular disease.

KEYWORDS:

GN; autoantibodies; endothelium; glomerulosclerosis; inflammation; nephrotic syndrome; podocytes; translational and clinical research

PMID:
24700796
PMCID:
PMC4046719
DOI:
10.2215/CJN.01450214
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center